Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07854808 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Trial Without Borders IMPLEMENT-CKD: IMPLEMENTation of Evidence-Based SGLT2i to Reduce Global Burden of Cardiovascular and Chronic Kidney Disease

Study acronym: IMPLEMENT-CKD
StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Chronic kidney disease (CKD) affects millions, especially in low- and middle-income countries, where many die early due to lack of treatment. One group of medicines, called SGLT2 inhibitors (SGLT2i), have been shown to slow down kidney damage and reduce the risk of heart-related deaths. The IMPLEMENT-CKD project will work with communities in Thailand, Fiji and Samoa to make it easier for people with CKD or type 2 diabetes to get these life-saving medicines as part of their regular care.
Trial Details
NCT Number NCT07854808
Lead Sponsor The University of Queensland
Conditions
(from sponsor)		 Implementation Research, Kidney Disease, Cardiovascular Disease, Chronic Illness
Related terms Cardiovascular Diseases, Chronic Disease, Kidney Diseases
Enrollment 1,390 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov